Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2

Mostrar otras versiones (1)

Drug repurposing is a rapid approach to identifying therapeutics for the treatment of emerging infectious diseases such as COVID-19. To address the urgent need for treatment options, we carried out a quantitative high-throughput screen using a SARS-CoV-2 cytopathic assay with a compound collection o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Catherine Z., Shinn, Paul, Itkin, Zina, Eastman, Richard T., Bostwick, Robert, Rasmussen, Lynn, Huang, Ruili, Shen, Min, Hu, Xin, Wilson, Kelli M., Brooks, Brianna, Guo, Hui, Zhao, Tongan, Klump-Thomas, Carleen, Simeonov, Anton, Michael, Samuel G., Lo, Donald C., Hall, Matthew D., Zheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444282/
https://www.ncbi.nlm.nih.gov/pubmed/32839771
http://dx.doi.org/10.1101/2020.08.18.255877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444282/
https://www.ncbi.nlm.nih.gov/pubmed/32839771
http://dx.doi.org/10.1101/2020.08.18.255877

Ejemplares similares